prednisone has been researched along with Nasal Polyps in 59 studies
Prednisone: A synthetic anti-inflammatory glucocorticoid derived from CORTISONE. It is biologically inert and converted to PREDNISOLONE in the liver.
prednisone : A synthetic glucocorticoid drug that is particularly effective as an immunosuppressant, and affects virtually all of the immune system. Prednisone is a prodrug that is converted by the liver into prednisolone (a beta-hydroxy group instead of the oxo group at position 11), which is the active drug and also a steroid.
Nasal Polyps: Focal accumulations of EDEMA fluid in the NASAL MUCOSA accompanied by HYPERPLASIA of the associated submucosal connective tissue. Polyps may be NEOPLASMS, foci of INFLAMMATION, degenerative lesions, or malformations.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Steroid-dependent, chronic asthmatic patients with severe rhinitis or nasal polyps are often candidates for treatment with intranasal topical corticosteroids, such as flunisolide." | 9.05 | Efficacy of safety of concurrent use of intranasal flunisolide and oral beclomethasone aerosols in treatment of asthmatics with rhinitis. ( Crepea, SB; Jennings, B; Johnson, JD; Toogood, JH, 1982) |
| "Patients with severe nasal polyps were randomized into two groups after a 4-week steroid washout period (w0): a treatment group received oral prednisone for 2 weeks (w2) and intranasal budesonide for 12 weeks (w12) while the control group received no steroid treatment." | 5.16 | Oral and intranasal steroid treatments improve nasal patency and paradoxically increase nasal nitric oxide in patients with severe nasal polyposis. ( Alobid, I; Benitez, P; Langdon, C; Mullol, J; Munoz, R; Valero, A, 2012) |
| "Patients with nasal polyps were randomly (3:1) treated (n = 51) or not (n = 14) with oral prednisone and intranasal budesonide for 2 weeks, plus intranasal budesonide for 10 additional weeks." | 5.13 | Regulation of glucocorticoid receptor in nasal polyps by systemic and intranasal glucocorticoids. ( Alobid, I; Benítez, P; Fokkens, WJ; Martínez-Antón, A; Mullol, J; Picado, C; Pujols, L; Roca-Ferrer, J, 2008) |
| "Patients with severe nasal polyps received either oral prednisone (n = 60) or no steroid treatment (control group, n = 18) for 2 weeks." | 5.12 | Severe nasal polyposis and its impact on quality of life. The effect of a short course of oral steroids followed by long-term intranasal steroid treatment. ( Alobid, I; Benitez, P; Bernal-Sprekelsen, M; Maldonado, M; Morello, A; Mullol, J; Picado, C; Pujols, L, 2006) |
| "Steroid-dependent, chronic asthmatic patients with severe rhinitis or nasal polyps are often candidates for treatment with intranasal topical corticosteroids, such as flunisolide." | 5.05 | Efficacy of safety of concurrent use of intranasal flunisolide and oral beclomethasone aerosols in treatment of asthmatics with rhinitis. ( Crepea, SB; Jennings, B; Johnson, JD; Toogood, JH, 1982) |
| "Inhibition of P-gp enhances the intracellular accumulation of prednisone in nasal polyps." | 3.80 | P-glycoprotein inhibition promotes prednisone retention in human sinonasal polyp explants. ( Bleier, BS; Feldman, R; Han, X; Kocharyan, A; Singleton, A, 2014) |
| " In total, 65 patients with nasal polyps were randomly (3:1) treated with (n = 51; 33 with asthma) or without (n = 14) oral prednisone and intranasal budesonide for 2 weeks plus intranasal budesonide for 10 additional weeks." | 3.75 | Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo. ( Alobid, I; Benitez, P; Martinez-Antón, A; Mullol, J; Picado, C; Pujols, L; Roca-Ferrer, J, 2009) |
| "Twice daily budesonide transnasal nebulization is an effective and safe treatment as evidenced by significant improvements in nasal symptoms and reduction in polyp size, coupled with an absence of hypothalamic-pituitary-adrenal axis suppression, which is safer than the systemic corticosteroids." | 2.80 | [The efficacy and safety of budesonide inhalation suspension via transnasal nebulization compared with oral corticosteroids in chronic rhinosinusitis with nasal polyps]. ( Lou, H; Wang, C; Zhang, L, 2015) |
| "Benign nasal polyps are lesions that arise from the mucosa of the nasal cavity or one or more of the nasal sinuses." | 2.44 | Oral steroids for nasal polyps. ( Patiar, S; Reece, P, 2007) |
| "Sarcoidosis is an ubiquity disease, which can infiltrate all tissues." | 1.34 | [Naso-sinusienne sarcoidosis]. ( Ben Gamra, O; Bousaffa, H; Chedly, I; El Khedim, A; Hariga, I; Khayat, O; Ktari, S; M'Barek, C; Zribi, S, 2007) |
| " The daily dosage of prednisolone and beclomethasone was progressively decreased while the gain in nasal comfort was being preserved." | 1.32 | Corticosteroid treatment in nasal polyposis with a three-year follow-up period. ( Avan, P; Bonfils, P; Halimi, P; Norès, JM, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 9 (15.25) | 18.7374 |
| 1990's | 7 (11.86) | 18.2507 |
| 2000's | 17 (28.81) | 29.6817 |
| 2010's | 21 (35.59) | 24.3611 |
| 2020's | 5 (8.47) | 2.80 |
| Authors | Studies |
|---|---|
| Tan, LH | 1 |
| Lin, C | 1 |
| Ungerer, H | 1 |
| Kumar, A | 1 |
| Qatanani, A | 1 |
| Adappa, ND | 1 |
| Palmer, JN | 1 |
| Bosso, JV | 1 |
| Reed, D | 1 |
| Cohen, NA | 1 |
| Kohanski, MA | 1 |
| Deng, J | 1 |
| Wang, Z | 1 |
| Xu, Z | 1 |
| Lai, Y | 1 |
| Zheng, R | 2 |
| Gao, W | 2 |
| Shi, J | 4 |
| Sun, Y | 2 |
| Epperson, MV | 1 |
| Phillips, KM | 1 |
| Caradonna, DS | 1 |
| Gray, ST | 1 |
| Sedaghat, AR | 1 |
| Arancibia, C | 1 |
| Langdon, C | 2 |
| Mullol, J | 9 |
| Alobid, I | 9 |
| Workman, AD | 1 |
| Miyake, MM | 1 |
| Nocera, AL | 1 |
| Mueller, SK | 1 |
| Finn, K | 1 |
| Otu, HH | 1 |
| Libermann, TA | 1 |
| Bleier, BS | 2 |
| Lu, H | 1 |
| Lin, XS | 1 |
| Yao, DM | 1 |
| Zhuang, YY | 1 |
| Wen, GF | 1 |
| Sun, YQ | 1 |
| Brunet, BA | 1 |
| Sugg, RM | 1 |
| Stewart, P | 1 |
| Tajudeen, BA | 1 |
| Ganti, A | 1 |
| Kuhar, HN | 1 |
| Mahdavinia, M | 1 |
| Heilingoetter, A | 1 |
| Gattuso, P | 1 |
| Ghai, R | 1 |
| Batra, PS | 1 |
| Wang, K | 1 |
| Yang, Q | 1 |
| Chen, Y | 1 |
| Wang, D | 1 |
| Zhou, M | 1 |
| Cao, YJ | 1 |
| Lee, A | 1 |
| Ellul, D | 1 |
| Sommerville, J | 1 |
| Earnshaw, J | 1 |
| Sullivan, TJ | 1 |
| García Juárez, I | 1 |
| Miquel, R | 1 |
| Forns, X | 1 |
| Bruguera, M | 1 |
| Edward, JA | 1 |
| Sanyal, M | 1 |
| Ramakrishnan, VR | 1 |
| Le, W | 1 |
| Nguyen, AL | 1 |
| Kingdom, TT | 1 |
| Hwang, PH | 1 |
| Nayak, JV | 1 |
| Dautremont, JF | 1 |
| Mechor, B | 1 |
| Rudmik, L | 1 |
| Kocharyan, A | 1 |
| Feldman, R | 1 |
| Singleton, A | 1 |
| Han, X | 1 |
| Walford, HH | 1 |
| Lund, SJ | 1 |
| Baum, RE | 1 |
| White, AA | 1 |
| Bergeron, CM | 1 |
| Husseman, J | 1 |
| Bethel, KJ | 1 |
| Scott, DR | 1 |
| Khorram, N | 1 |
| Miller, M | 1 |
| Broide, DH | 1 |
| Doherty, TA | 1 |
| Hong, SJ | 1 |
| Lee, JK | 1 |
| Lee, HS | 1 |
| Lee, JY | 1 |
| Pyo, JS | 1 |
| Lee, KC | 1 |
| Chen, X | 1 |
| Luo, X | 1 |
| Han, M | 1 |
| Wu, X | 1 |
| Guo, J | 1 |
| Zhang, J | 1 |
| Tang, H | 1 |
| Zuo, K | 1 |
| Xu, G | 2 |
| Li, H | 2 |
| de Borja Callejas, F | 1 |
| Martínez-Antón, A | 4 |
| Picado, C | 7 |
| Pujols, L | 5 |
| Valero, A | 2 |
| Roca-Ferrer, J | 4 |
| Lou, H | 1 |
| Wang, C | 1 |
| Zhang, L | 2 |
| Martinez-Devesa, P | 2 |
| Patiar, S | 3 |
| de Bolós, C | 1 |
| Benítez, P | 7 |
| Fokkens, WJ | 1 |
| Li, CW | 1 |
| Cheung, W | 1 |
| Lin, ZB | 1 |
| Li, TY | 1 |
| Lim, JT | 1 |
| Wang, DY | 1 |
| Cardoso, CL | 1 |
| Damante, JH | 1 |
| Santos, PS | 1 |
| Taveira, LA | 1 |
| Fernandes, LM | 1 |
| Pigatti, FM | 1 |
| Soares, CT | 1 |
| Coelho, RF | 1 |
| Wen, W | 1 |
| Liu, W | 1 |
| Bai, J | 1 |
| Fan, Y | 1 |
| Xia, W | 1 |
| Luo, Q | 1 |
| Zheng, J | 1 |
| Wang, H | 1 |
| Li, Z | 1 |
| Xia, J | 1 |
| Jiang, H | 1 |
| Liu, Z | 1 |
| Munoz, R | 1 |
| González-Castro, J | 1 |
| Pascual, J | 1 |
| Busquets, J | 1 |
| Aversa, S | 1 |
| Ondolo, C | 1 |
| Abbadessa, G | 1 |
| Piccione, F | 1 |
| Carriero, V | 1 |
| Fulcheri, A | 1 |
| Lauria, A | 1 |
| De Francia, S | 1 |
| Racca, S | 1 |
| Bonfils, P | 2 |
| Norès, JM | 1 |
| Halimi, P | 1 |
| Avan, P | 2 |
| HOTCHKISS, WT | 2 |
| TAUB, SJ | 1 |
| SCHWARTZ, E | 1 |
| Woodworth, BA | 1 |
| Joseph, K | 1 |
| Kaplan, AP | 1 |
| Schlosser, RJ | 1 |
| Bernal-Sprekelsen, M | 3 |
| Roca, J | 1 |
| Alonso, J | 1 |
| Maldonado, M | 1 |
| Morello, A | 1 |
| Kokan, N | 1 |
| Hosomi, Y | 1 |
| Inamoto, S | 1 |
| Ohnishi, K | 1 |
| Tanimoto, H | 1 |
| Nibu, K | 1 |
| de Haro, J | 1 |
| Berenguer, J | 1 |
| Bacciu, A | 1 |
| Bacciu, S | 1 |
| Mercante, G | 1 |
| Ingegnoli, F | 1 |
| Grasselli, C | 1 |
| Vaglio, A | 1 |
| Pasanisi, E | 1 |
| Vincenti, V | 1 |
| Garini, G | 1 |
| Ronda, N | 1 |
| Ferri, T | 1 |
| Corradi, D | 1 |
| Buzio, C | 1 |
| Sieskiewicz, A | 1 |
| Olszewska, E | 1 |
| Rogowski, M | 1 |
| Grycz, E | 1 |
| Reece, P | 1 |
| Landsberg, R | 1 |
| Segev, Y | 1 |
| DeRowe, A | 1 |
| Landau, T | 1 |
| Khafif, A | 1 |
| Fliss, DM | 1 |
| Wright, ED | 1 |
| Agrawal, S | 1 |
| Zribi, S | 1 |
| M'Barek, C | 1 |
| Ben Gamra, O | 1 |
| Bousaffa, H | 1 |
| Hariga, I | 1 |
| Khayat, O | 1 |
| Chedly, I | 1 |
| Ktari, S | 1 |
| El Khedim, A | 1 |
| Busse, WW | 1 |
| Webb, DR | 1 |
| Toogood, JH | 1 |
| Jennings, B | 1 |
| Crepea, SB | 1 |
| Johnson, JD | 1 |
| Zrunek, M | 1 |
| Kürsten, R | 1 |
| Erlacher, L | 1 |
| Wagner, A | 1 |
| Knoflach, B | 1 |
| Chott, A | 1 |
| Luger, A | 1 |
| Radaszkiewicz, T | 1 |
| Shiotani, A | 1 |
| Mukobayashi, C | 1 |
| Oohata, H | 1 |
| Yamanishi, T | 1 |
| Hara, T | 1 |
| Itoh, H | 1 |
| Nishioka, S | 1 |
| Graham, SM | 1 |
| Ballas, ZK | 1 |
| Colović, MD | 1 |
| Janković, GM | 1 |
| Cemerikić-Martinović, V | 1 |
| Latković, Z | 1 |
| Donfrid, M | 1 |
| Tomasi, M | 1 |
| Le Mouel, P | 1 |
| Miltgen, J | 1 |
| Bonnet, D | 1 |
| Charpentier, P | 1 |
| Salgas, P | 1 |
| Jahnsen, FL | 1 |
| Haye, R | 1 |
| Gran, E | 1 |
| Brandtzaeg, P | 1 |
| Johansen, FE | 1 |
| Amanou, L | 1 |
| Valcke, JC | 1 |
| Imbeau, SA | 1 |
| Yin, M | 1 |
| Myers, D | 1 |
| Myers, EN | 1 |
| Rowe, AH | 1 |
| Rowe, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| The Role of Postoperative Systemic Corticosteroids When Utilizing a Steroid-Eluting Middle Meatal Spacer Following Endoscopic Sinus Surgery: A Randomized, Double-Blind, Placebo Controlled Trial[NCT01564355] | 80 participants (Actual) | Interventional | 2012-04-30 | Completed | |||
| Prednisone in Chronic Rhinosinusitis Without Nasal Polyps. A Double-blind, Randomized, Placebo-controlled Trial[NCT02367118] | Phase 3 | 90 participants (Anticipated) | Interventional | 2015-06-30 | Recruiting | ||
| The Effect of Preoperative Oral Prednisone on the Operative Field During Nasal Polypectomy.[NCT00440219] | Phase 3 | 34 participants (Anticipated) | Interventional | 2010-11-30 | Completed | ||
| Effect of Pre-operative Oral Steroids on Blood Loss in Endoscopic Sinus Surgery for Chronic Rhinosinusitis Without Polyps[NCT05095961] | Phase 2/Phase 3 | 0 participants (Actual) | Interventional | 2023-03-31 | Withdrawn (stopped due to Technical difficulties encountered with recording intraoperative blood loss; unable to proceed with study.) | ||
| A Prospective, Randomized, Controlled Trial of Steroid Delivery to the Frontal Sinus Opening With a Bioabsorbable Steroid Releasing Implant vs. a Bioabsorbable Nasal Dressing With Added Steroid[NCT03188822] | 9 participants (Actual) | Interventional | 2017-08-25 | Terminated (stopped due to Study enrollment was too slow to complete the study in a reasonable time) | |||
| Effect of Celecoxib on Postoperative Narcotic Use and Disease Severity in Patients With Aspirin-exacerbated Respiratory Disease and Chronic Rhinosinusitis: a Randomised Controlled Trial[NCT04147013] | Phase 4 | 44 participants (Anticipated) | Interventional | 2020-02-18 | Recruiting | ||
| High Volume Saline Irrigation in the Post-operative Management of Chronic Rhinosinusitis: A Multicenter Randomized Single-Blind Controlled Trial[NCT02636959] | Early Phase 1 | 20 participants (Anticipated) | Interventional | 2015-12-31 | Recruiting | ||
| Glucocorticosteroid Action in Inflammatory Disease[NCT00841802] | Phase 4 | 0 participants (Actual) | Interventional | 2008-07-31 | Withdrawn (stopped due to Realized there was a design flaw.) | ||
| Ideal Frequency of Postoperative High Volume Saline Irrigations Following Endoscopic Sinus Surgery[NCT01680705] | 75 participants (Actual) | Interventional | 2012-07-31 | Completed | |||
| Comparison of the Posterior Septectomy and Stamm Approach to Endoscopic Pituitary Adenoma Resection: A Randomized, Single-blind Trial[NCT01689064] | 55 participants (Anticipated) | Interventional | 2012-09-30 | Completed | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Average adhesion/scarring Likert scale score (range from 0 to 4 with higher numbers indicating worse health) for appearance of the Frontal sinus opening after bioabsorbable steroid releasing implant placement - Left side (NCT03188822)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| adhesion/scarring Likert scale score of 0 | adhesion/scarring Likert scale score of 1 | |
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 3 | 0 |
Average adhesion/scarring Likert scale score (range from 0 to 4 with higher numbers indicating worse health) for appearance of the Frontal sinus opening after bioabsorbable nasal dressing with added steroid placement (NCT03188822)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) | |
|---|---|---|
| adhesion/scarring Likert scale score of 0 | adhesion/scarring Likert scale score of 1 | |
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 2 | 1 |
Grading by a blinded independent sinus expert as to whether the propel sinus stent frontal sinusotomy side is better, worse or the same, in terms of overall appearance after implant removal (NCT03188822)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| propel sinus stent frontal sinusotomy side is better | propel sinus stent frontal sinusotomy side is same | propel sinus stent frontal sinusotomy side is worse | |
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 0 | 1 | 1 |
Grading by a blinded independent sinus expert as to whether the propel sinus stent frontal sinusotomy side is better, worse or the same, in terms of overall appearance after implant removal (NCT03188822)
Timeframe: 30 Days
| Intervention | Participants (Count of Participants) | ||
|---|---|---|---|
| propel sinus stent frontal sinusotomy side is better | propel sinus stent frontal sinusotomy side is same | propel sinus stent frontal sinusotomy side is worse | |
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 2 | 3 | 3 |
Average polypoid edema Likert scale score (range from 0 to 4 with higher numbers indicating worse health) for appearance of the Frontal sinus opening after bioabsorbable steroid releasing implant placement (NCT03188822)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| polypoid edema Likert score 0 | polypoid edema Likert score 1 | polypoid edema Likert score 2 | polypoid edema Likert score 3 | polypoid edema Likert score 4 | |
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 0 | 0 | 0 | 0 | 3 |
Average polypoid edema Likert scale score (range from 0 to 4 with higher numbers indicating worse health) for appearance of the Frontal sinus opening after bioabsorbable nasal dressing with added steroid placement (NCT03188822)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) | ||||
|---|---|---|---|---|---|
| polypoid edema Likert score 0 | polypoid edema Likert score 1 | polypoid edema Likert score 2 | polypoid edema Likert score 3 | polypoid edema Likert score 4 | |
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 1 | 0 | 0 | 0 | 2 |
Frontal sinus opening greater than or equal to 4 mm for bioabsorbable steroid releasing implant vs. bioabsorbable nasal dressing with added steroid (NCT03188822)
Timeframe: 12 months
| Intervention | Participants (Count of Participants) | |||
|---|---|---|---|---|
| Left72159548 | Right72159548 | |||
| Yes | No | |||
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 0 | |||
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 3 | |||
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 1 | |||
| Bioabsorbable Steroid Releasing Sinus Implant & Nasal Dressing Impregnated With Steroid | 2 | |||
6 reviews available for prednisone and Nasal Polyps
| Article | Year |
|---|---|
WITHDRAWN: Oral steroids for nasal polyps.
Topics: Administration, Oral; Humans; Nasal Obstruction; Nasal Polyps; Olfaction Disorders; Prednisone; Rand | 2016 |
Oral steroids for nasal polyps.
Topics: Administration, Oral; Humans; Nasal Obstruction; Nasal Polyps; Olfaction Disorders; Prednisone; Rand | 2011 |
Rosai-Dorfman disease with widespread oral-maxillofacial manifestations: a case report.
Topics: Cellulitis; Emperipolesis; Facial Bones; Female; Glucocorticoids; Histiocytosis, Sinus; Humans; Midd | 2012 |
Oral steroids for nasal polyps.
Topics: Administration, Oral; Humans; Nasal Obstruction; Nasal Polyps; Olfaction Disorders; Prednisone; Ster | 2007 |
Steroids in allergic disease.
Topics: Administration, Intranasal; Adrenal Cortex Hormones; Asthma; Beclomethasone; Cataract; Cushing Syndr | 1981 |
[Nasal polyps].
Topics: Combined Modality Therapy; Humans; Nasal Polyps; Prednisone | 1991 |
16 trials available for prednisone and Nasal Polyps
37 other studies available for prednisone and Nasal Polyps
| Article | Year |
|---|---|
Steroid affected cytokines in aspirin-exacerbated respiratory disease.
Topics: Aspirin; Asthma, Aspirin-Induced; Cytokines; Granulocyte-Macrophage Colony-Stimulating Factor; Human | 2022 |
Predictors of efficacy for combination oral and topical corticosteroids to treat patients with chronic rhinosinusitis with nasal polyps.
Topics: Administration, Intranasal; Administration, Oral; Adrenal Cortex Hormones; Adult; Aged; Budesonide; | 2019 |
Unexpected effects of systemic steroids on the CRSwNP proteome: is protein upregulation more important than inhibition?
Topics: Adult; Anti-Inflammatory Agents; Chronic Disease; Exosomes; Female; Glucocorticoids; Humans; Male; M | 2020 |
Hypereosinophilic syndrome presenting acutely with neurologic signs.
Topics: Aged; Anti-Inflammatory Agents; Antibodies, Monoclonal, Humanized; Arthralgia; Chronic Disease; Chur | 2018 |
The presence of eosinophil aggregates correlates with increased postoperative prednisone requirement.
Topics: Anti-Inflammatory Agents; Chronic Disease; Eosinophilia; Eosinophils; Female; Humans; Leukocyte Coun | 2019 |
Comparison of subjective and objective assessment of glucocorticoid response in nasal polyps: a preliminary study.
Topics: Adolescent; Adult; Eosinophilia; Female; Glucocorticoids; Humans; Male; Middle Aged; Nasal Polyps; N | 2019 |
Bony orbital changes in allergic fungal sinusitis are reversible after treatment.
Topics: Adult; Endoscopy; Female; Humans; Hypersensitivity; Mycoses; Nasal Obstruction; Nasal Polyps; Orbita | 2020 |
[Levofloxacin-induced autoimmune hepatitis. Description of a case].
Topics: Adrenal Cortex Hormones; Alanine Transaminase; Anti-Asthmatic Agents; Aspartate Aminotransferases; A | 2014 |
Systemic prednisone administration selectively alters granulocyte subsets in nasal polyps from aspirin-exacerbated respiratory disease and chronic rhinosinusitis patients.
Topics: Adult; Aged; Aspirin; Chronic Disease; Ethmoid Sinus; Female; Flow Cytometry; Glucocorticoids; Granu | 2013 |
P-glycoprotein inhibition promotes prednisone retention in human sinonasal polyp explants.
Topics: Anti-Inflammatory Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cytoplasm; Dibenz | 2014 |
Increased ILC2s in the eosinophilic nasal polyp endotype are associated with corticosteroid responsiveness.
Topics: Adult; Animals; Anti-Inflammatory Agents; Dexamethasone; Female; Humans; Lymphocytes; Male; Methylpr | 2014 |
Availability of preoperative systemic steroids on endoscopic sinus surgery for chronic rhinosinusitis with nasal polyposis.
Topics: Adult; Aged; Asthma; Chronic Disease; Endoscopy; Female; Humans; Inflammation; Male; Middle Aged; Na | 2014 |
Corticosteroid regulates epithelial occludin expression in nasal polyps through a MKP-1-dependent pathway.
Topics: Adult; Blotting, Western; Bronchi; Cells, Cultured; Epithelial Cells; Female; Glucocorticoids; Human | 2014 |
Corticosteroid treatment regulates mucosal remodeling in chronic rhinosinusitis with nasal polyps.
Topics: Administration, Intranasal; Administration, Oral; Biopsy; Budesonide; Chronic Disease; Collagenases; | 2015 |
Oral steroids enhance epithelial repair in nasal polyposis via upregulation of the AP-1 gene network.
Topics: Administration, Oral; Adult; Case-Control Studies; Chronic Disease; Extracellular Space; Female; Gen | 2009 |
Glucocorticoid therapy increases COX-2 gene expression in nasal polyps in vivo.
Topics: Administration, Oral; Adult; Asthma; Biopsy; Budesonide; Cyclooxygenase 1; Cyclooxygenase 2; Female; | 2009 |
Increased neutrophilia in nasal polyps reduces the response to oral corticosteroid therapy.
Topics: Administration, Oral; Adult; Case-Control Studies; Cytokines; Female; Humans; Inflammation Mediators | 2012 |
National survey on the use of preoperative systemic steroids in endoscopic sinus surgery.
Topics: Chronic Disease; Cross-Sectional Studies; Endoscopy; Glucocorticoids; Health Care Surveys; Humans; M | 2013 |
Steroid resistance in nasal polyposis: role of glucocorticoid receptor and TGF-beta1.
Topics: Drug Resistance; Electrophoresis, Polyacrylamide Gel; Endoscopy; Female; Glucocorticoids; Humans; Ma | 2012 |
Corticosteroid treatment in nasal polyposis with a three-year follow-up period.
Topics: Administration, Intranasal; Anti-Inflammatory Agents; Beclomethasone; Female; Follow-Up Studies; Hum | 2003 |
Influence of prednisone on nasal polyposis with anosmia; preliminary report.
Topics: Humans; Nasal Polyps; Olfaction Disorders; Prednisone; Smell | 1956 |
Influence of prednisone on nasal polyposis with anosmia; preliminary report.
Topics: Humans; Nasal Polyps; Olfaction Disorders; Prednisone; Smell | 1956 |
Influence of prednisone on nasal polyposis with anosmia; preliminary report.
Topics: Humans; Nasal Polyps; Olfaction Disorders; Prednisone; Smell | 1956 |
Influence of prednisone on nasal polyposis with anosmia; preliminary report.
Topics: Humans; Nasal Polyps; Olfaction Disorders; Prednisone; Smell | 1956 |
THE DIAGNOSIS AND TREATMENT OF ASTHMA IN THE ELDERLY.
Topics: Aerosols; Aged; Asthma; Betamethasone; Bronchiectasis; Bronchitis; Dexamethasone; Dyspnea; Dyspnea, | 1964 |
Metacortandracin (prednisone) in bronchial asthma: comparative effects of metacortandracin, hydrocortisone, and cortisone in bronchial asthma with diabetes mellitus and bronchial asthma with nasal polyps; preliminary report.
Topics: Adrenal Cortex; Adrenal Cortex Hormones; Asthma; Cortisone; Diabetes Complications; Hydrocortisone; | 1955 |
Alterations in eotaxin, monocyte chemoattractant protein-4, interleukin-5, and interleukin-13 after systemic steroid treatment for nasal polyps.
Topics: Adrenal Cortex Hormones; Adult; Chemokine CCL11; Chemokines, CC; Endoscopy; Female; Humans; Interleu | 2004 |
Microscopic polyangiitis histologically confirmed by biopsy from nasal cavity and paranasal sinuses: a case report.
Topics: Administration, Oral; Anti-Inflammatory Agents; Antibodies, Antineutrophil Cytoplasmic; Biopsy; Chro | 2006 |
Ear, nose and throat manifestations of Churg-Strauss syndrome.
Topics: Administration, Oral; Adolescent; Adult; Aged; Asthma; Chronic Disease; Churg-Strauss Syndrome; Coho | 2006 |
Systemic corticosteroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal polyposis: a comparative study.
Topics: Adolescent; Adult; Chronic Disease; Endoscopy; Female; Glucocorticoids; Humans; Male; Mycoses; Nasal | 2007 |
[Naso-sinusienne sarcoidosis].
Topics: Adult; Anti-Inflammatory Agents; Diagnosis, Differential; Endoscopy; Female; Follow-Up Studies; Gluc | 2007 |
Chronic rhinitis. A systematic approach to diagnosis and treatment.
Topics: Acute Disease; Adrenal Cortex Hormones; Adult; Beclomethasone; Cromolyn Sodium; Eosinophilia; Female | 1983 |
[Manifestation of malignant lymphomatous polyposis of the nasopharynx].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Endoscopy; Huma | 1993 |
Wegener's granulomatosis with dural involvement as the initial clinical manifestation.
Topics: Adult; Antibodies, Antineutrophil Cytoplasmic; Autoimmune Diseases; Biopsy; Cyclophosphamide; Dura M | 1997 |
Preoperative steroids confuse the diagnosis of allergic fungal sinusitis.
Topics: Adult; Diagnostic Errors; Glucocorticoids; Humans; Hypersensitivity; Male; Mycoses; Nasal Polyps; Pr | 1998 |
Primary intraocular marginal zone B-cell (MALT) lymphoma.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Doxorubicin; Eye Neoplasms; | 1998 |
[Carrington's disease associated with naso-sinusal polyposis].
Topics: Anti-Inflammatory Agents; Humans; Male; Middle Aged; Nasal Polyps; Prednisone; Pulmonary Eosinophili | 1998 |
Aerosol beclomethasone treatment of chronic severe asthma. A one-year experience.
Topics: Administration, Oral; Aerosols; Asthma; Beclomethasone; Humans; Nasal Polyps; Pharyngitis; Prednison | 1978 |
The medical and surgical treatment of nasal polyps.
Topics: Administration, Oral; Adrenal Cortex Hormones; Adrenocorticotropic Hormone; Anti-Bacterial Agents; C | 1974 |
Perennial nasal allergy due to food sensitization.
Topics: Adolescent; Adult; Child; Child, Preschool; Diet Therapy; Female; Food Hypersensitivity; Humans; Inf | 1965 |